This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Respiratory Distress Syndrome
and you are
between 18 and 100
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Compared with placebo, evaluate the effects and safety of Ulinastatin(UTI) added to conventional treatment for ARDS; Evaluate the dose response relationship of Ulinastatin for ARDS.

Provided treatments

  • Drug: ulinastatin
  • Drug: placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02895191. The sponsor of the trial is Techpool Bio-Pharma Co., Ltd. and it is looking for 60 volunteers for the current phase.
Official trial title:
A Randomized, Blind, Placebo-controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)